Impact of Renal Insufficiency on Angiographic, Procedural, and In-Hospital Outcomes Following Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 101, Issue 6, 2008, Pages 780-785

  Osten, Mark D ^a   Ivanov, Joan ^a   Eichhofer, Jonas ^a   Seidelin, Peter H ^a   Ross, John R ^a   Barolet, Alan ^a   Horlick, Eric M ^a   Ing, Douglas ^a   Schwartz, Leonard ^a   Mackie, Karen ^a   Džavík, Vladimír ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; CREATININE CLEARANCE; DEATH; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; OUTCOME ASSESSMENT; OUTCOME VARIABLE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; REGISTER;

AGED; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; ODDS RATIO; ONTARIO; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY;

EID: 40049111536     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.009     Document Type: Article

References (26)

1. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., and Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
2. Blackman D.J., Pinto R., Ross J.R., Seidelin P.H., Ing D., Jackevicius C., Mackie K., Chan C., and Dzavik V. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 151 (2006) 146-152
3. Lemos P.A., Arampatzis C.A., Hoye A., Daemen J., Ong A.T., Saia F., van der Giessen W.J., McFadden E.P., Sianos G., Smits P.C., et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95 (2005) 167-172
4. Rubenstein M.H., Sheynberg B.V., Harrell L.C., Schunkert H., Bazari H., and Palacios I.F. Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 87 (2001) 856-860
5. Rubenstein M.H., Harrell L.C., Sheynberg B.V., Schunkert H., Bazari H., and Palacios I.F. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation 102 (2000) 2966-2972
6. Gruberg L., Weissman N.J., Waksman R., Laird Jr. J.R., Pinnow E.E., Wu H., Deible R., Kent K.M., Pichard A.D., Satler L.F., and Lindsay Jr. J. Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency. Am J Cardiol 89 (2002) 54-57
7. Sadeghi H.M., Stone G.W., Grines C.L., Mehran R., Dixon S.R., Lansky A.J., Fahy M., Cox D.A., Garcia E., Tcheng J.E., et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2975
8. Szczech L.A., Best P.J., Crowley E., Brooks M.M., Berger P.B., Bittner V., Gersh B.J., Jones R., Califf R.M., Ting H.H., et al. Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation. Circulation 105 (2002) 2253-2258
9. Tadros G.M., and Herzog C.A. Percutaneous coronary intervention in chronic kidney disease patients. J Nephrol 17 (2004) 364-368
10. Yamaguchi J., Kasanuki H., Ishii Y., Yagi M., Ogawa H., Fujii S.Y., Koganei H., Okada H., Kimura H., Horie T., et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol 93 (2004) 1526-1528
11. Naidu S.S., Selzer F., Jacobs A., Faxon D., Marks D.S., Johnston J., Detre K., and Wilensky R.L. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 92 (2003) 1160-1164
12. Azar R.R., Prpic R., Ho K.K., Kiernan F.J., Shubrooks Jr. S.J., Baim D.S., Popma J.J., Kuntz R.E., and Cohen D.J. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 86 (2000) 485-489
13. Rinehart A.L., Herzog C.A., Collins A.J., Flack J.M., Ma J.Z., and Opsahl J.A. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 25 (1995) 281-290
14. Ahmed W.H., Shubrooks S.J., Gibson C.M., Baim D.S., and Bittl J.A. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 128 (1994) 252-255
15. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
16. Ryan T.J., Faxon D.P., Gunnar R.M., Kennedy J.W., King III S.B., Loop F.D., Peterson K.L., Reeves T.J., Williams D.O., Winters Jr. W.L., et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 78 (1988) 486-502
17. Smith Jr. S.C., Dove J.T., Jacobs A.K., Kennedy J.W., Kereiakes D., Kern M.J., Kuntz R.E., Popma J.J., Schaff H.V., Williams D.O., et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 37 (2001) 2215-2239
18. Russo D., Palmiero G., De Blasio A.P., Balletta M.M., and Andreucci V.E. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44 (2004) 1024-1030
19. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D., Wang Y., Chung J., Emerick A., Greaser L., Elashoff R.M., and Salusky I.B. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
20. Campean V., Neureiter D., Varga I., Runk F., Reiman A., Garlichs C., Achenbach S., Nonnast-Daniel B., and Amann K. Atherosclerosis and vascular calcification in chronic renal failure. Kidney Blood Press Res 28 (2005) 280-289
21. Rajagopalan S., Dellegrottaglie S., Furniss A.L., Gillespie B.W., Satayathum S., Lameire N., Saito A., Akiba T., Jadoul M., Ginsberg N., et al. Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114 (2006) 1914-1922
22. O'Hare A.M., Glidden D.V., Fox C.S., and Hsu C.Y. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 109 (2004) 320-323
23. Kaw D., and Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 19 (2006) 317-322
24. Gawaz M.P., Dobos G., Spath M., Schollmeyer P., Gurland H.J., and Mujais S.K. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol 5 (1994) 36-46
25. Frilling B., Zahn R., Fraiture B., Mark B., Donges K., Becker T., Siegler K.E., Seidl K., Rustige J., and Senges J. Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab. Am J Cardiol 89 (2002) 450-452
26. Kuchulakanti P.K., Torguson R., Chu W.W., Canos D.A., Rha S.W., Clavijo L., Deible R., Gevorkian N., Suddath W.O., Satler L.F., et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 97 (2006) 792-797